Linda-Gail Bekker
Linda-Gail Bekker is the chief operating officer of the Desmond Tutu HIV Foundation in South Africa, where she has been a leading voice in the fight against HIV/AIDS. With a career dedicated to improving health outcomes for those living with HIV, she has been instrumental in research and advocacy efforts. Bekker has warned that recent U.S. funding cuts could lead to a catastrophic increase in HIV-related deaths, projecting that as many as 600,000 lives could be lost over the next decade due to the loss of crucial health programs.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
South Africa:
Linda-Gail Bekker is the head of the Desmond Tutu Health Foundation at the University of Cape Town and led the trial that showed LEN fully protects young women against getting HIV through sex.
8
South Africa:
Linda-Gail Bekker will head up the Cape Town study on LEN.
8
Kenya:
Prof Linda-Gail Bekker is the CEO of the Desmond Tutu Health Foundation and discusses the limited research on Long COVID in Africa.
7
Panama:
Linda-Gail Bekker is a Zimbabwean scientist who presented data on the efficacy of Lenacapavir at the 25th World AIDS Conference.
8
South Africa:
Linda-Gail Bekker, an HIV scientist who heads the Desmond Tutu Health Foundation and was a co-chief investigator of the J&J Covid jab in South Africa.
8
South Africa:
Linda-Gail Bekker is the head of the Desmond Tutu Health Foundation, which has received NIH funding for many years.
8
South Africa:
Linda-Gail Bekker heads the Desmond Tutu Health Foundation and released groundbreaking results of a study on the anti-HIV shot, lenacapavir.
8
South Africa:
Linda-Gail Bekker heads the Desmond Tutu Health Foundation at the University of Cape Town and warns about the impact of funding cuts.
6
United Kingdom:
Prof Linda-Gail Bekker has seen US funding for trials of potential HIV vaccines cancelled.
5
South Africa:
Linda-Gail Bekker, who heads the Desmond Tutu Health Foundation, stresses the need for research on the uptake of the jab.
8